Skip to content
Disclosery

EXANE DERIVATIVES: PTH position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on PTH, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 925 PTH shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 925 shares
    Change vs previous 13F 0 shares

    0.06% of the 13F portfolio, value $106,131.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 925 shares
    Change vs previous 13F -157 shares

    0.04% of the 13F portfolio, value $124,460.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 1,082 shares
    Change vs previous 13F -812 shares

    0.04% of the 13F portfolio, value $167,650.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 1,894 shares
    Change vs previous 13F -222 shares

    0.08% of the 13F portfolio, value $304,942.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 2,116 shares
    Change vs previous 13F +200 shares

    0.08% of the 13F portfolio, value $352,729.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 1,916 shares
    Change vs previous 13F -3,289 shares

    0.09% of the 13F portfolio, value $300,875.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 5,205 shares
    Change vs previous 13F +3,138 shares

    0.25% of the 13F portfolio, value $833,126.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 2,067 shares
    Change vs previous 13F not available

    0.09% of the 13F portfolio, value $280,931.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).